FDA expands tamiflu use to treat babies under one year old

FDA expands tamiflu use to treat babies under 1 year old
Tamiflu can now be given to children as young as 2 weeks old under an expanded approval announced Friday by the U.S. Food and Drug Administration.

(HealthDay)—Tamiflu (oseltamivir) can now be given to children as young as 2 weeks old under an expanded approval announced Friday by the U.S. Food and Drug Administration.

Tamiflu can be used as treatment in children aged 2 weeks to 1 year if they have had for no longer than two days. The drug is not approved to prevent flu in these children and the safety and effectiveness of Tamiflu in children younger than 2 weeks of age has not been established.

While there are fixed dosing regimens for children 1 year and older according to weight categories, dosing for children younger than 1 year must be calculated individually based on exact weight, the FDA stressed. Children 2 weeks to 1 year of age should receive 3 milligrams per kilogram of weight twice daily for five days.

"Pharmacists must provide the proper dispenser when filling a prescription so parents can measure and administer the correct dose to their children," Edward Cox, M.D., M.P.H., director of the Office of in the FDA's Center for Drug Evaluation and Research, said in an FDA news release.

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Tamiflu touted for child use

Nov 16, 2007

The maker of the anti-viral Tamiflu said the drug is effective for treatment and prevention of influenza in young children.

FDA panel backs infant doses for kids' Tylenol

May 18, 2011

(AP) -- Federal health experts say dosing instructions for children younger than 2 years old should be added to Children's Tylenol and similar products containing acetaminophen, the popular pain reliever and fever reducer.

FDA issues Tussionex safety alert

Mar 11, 2008

The U.S. Food and Drug Administration issued a safety alert, saying incorrect usage of a specific cough medicine can result in serious health risks.

Two pancreatic-enzyme products approved

Mar 02, 2012

(HealthDay) -- Two drugs that supplement the digestion-aiding actions of pancreatic enzymes have been approved by the U.S. Food and Drug Administration, the agency said Thursday in a news release.

Recommended for you

FDA to start regulating lab-developed tests

21 hours ago

(AP)—The Food and Drug Administration announced Thursday it will begin regulating laboratory-developed tests, a growing class of medical diagnostics that have never before been subject to federal oversight.

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

cantdrive85
3 / 5 (4) Dec 22, 2012
The poisoning of our children continues...
PeterD
3.7 / 5 (3) Dec 23, 2012
The poisoning of our children continues...

You got that right. Tamiflu is completely worthless, and does nothing to benefit adults, let alone children. The FDA is a criminal organization that should be ended.